Coherus Oncology, Inc. Common Stock
CHRS
CHRS
122 hedge funds and large institutions have $90.5M invested in Coherus Oncology, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
-6
Holders Change %
-4.69%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
30
Reduced
34
Closed
35
Calls
$7.36M
Puts
$154K
Net Calls
+$7.21M
Net Calls Change
+$7.2M
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$7.29M |
| 2 |
TCM
2
Tang Capital Management
San Diego,
California
|
$5.04M |
| 3 |
3
Morgan Stanley
New York
|
$2.91M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$978K |
| 5 |
5
Millennium Management
New York
|
$1.45M |
Top Sellers
| 1 |
RCMNY
1
Rubric Capital Management (New York)
New York
|
$7.26M |
| 2 |
2
Barclays
London,
United Kingdom
|
$414K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$0 |
| 4 |
4
Goldman Sachs
New York
|
$738K |
| 5 |
5
BlackRock
New York
|
$15.3M |
